Factors correlated with fatigue in breast cancer patients before, during and after adjuvant chemotherapy: the FATSEIN study.

Fiche publication


Date publication

mars 2011

Journal

Contemporary clinical trials

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry, Pr GUILLEMIN Francis, Dr ROTONDA Christine


Tous les auteurs :
Rotonda C, Guillemin F, Bonnetain F, Conroy T

Résumé

Breast cancer is by far the most common form of cancer diagnosis in women. Cancer treatments are long, complex and often cumbersome with numerous side effects. Fatigue is now considered as the most distressing side effect of treatment. Fifty-eight percent to 94% of breast cancer patients experience fatigue during treatment with adjuvant chemotherapy.

Mots clés

Antineoplastic Agents, adverse effects, Breast Neoplasms, drug therapy, Chemotherapy, Adjuvant, adverse effects, Combined Modality Therapy, Fatigue, chemically induced, Female, Humans, Prospective Studies, Psychological Tests, Research Design, Sample Size, Stress, Psychological, etiology, Surveys and Questionnaires, Treatment Outcome

Référence

Contemp Clin Trials. 2011 Mar;32(2):244-9